Day: June 11, 2022

health news

Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Relapsed/Refractory Large B-cell Lymphoma (LBCL) Patients Presented at European Hematology Association (EHA) Presidential Symposium

Staff June 11, 2022

Media Release COPENHAGEN, Denmark; June 11, 2022  Epcoritamab demonstrated clinically meaningful efficacy in challenging to treat, highly refractory LBCL patients,...

Read MoreRead more about Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Relapsed/Refractory Large B-cell Lymphoma (LBCL) Patients Presented at European Hematology Association (EHA) Presidential Symposium
health news

Oncternal Therapeutics Presents New Preclinical Data from its anti-ROR1 Cell Therapy Collaboration with the Karolinska Institutet at the EHA2022 Congress

Staff June 11, 2022

SAN DIEGO, June 10, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...

Read MoreRead more about Oncternal Therapeutics Presents New Preclinical Data from its anti-ROR1 Cell Therapy Collaboration with the Karolinska Institutet at the EHA2022 Congress

You may have missed

health news

Genflow to Attend Healthcare Conference

Staff December 11, 2025
health news

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Staff December 10, 2025
health news

ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification

Staff December 10, 2025
health news

Early Data Shows that Coverage of Saliva-Based Screenings Drives Improved Patient Engagement and Treatment Plan Acceptance

Staff December 10, 2025
health news

Robert Half Selected by Newsweek as One of America’s Most Responsible Companies 2026

Staff December 10, 2025
error: Content is protected !!